surmount-1 trial tirzepatide non-diabetic weight loss for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity For the first time, tirzepatide

Key Takeaways Mounjaro is positioned to become a leading drug in the Type 2 diabetes and obesity markets with projected peak sales of $12 billion by 2030

FSA/HSA eligibility varies by plan Platform: 100% online intake, asynchronous or video consultation depending on state law, medication shipped directly to your door FDA regulatory window: FDA proposed 503B compounding exclusion for semaglutide and tirzepatide on April 30, 2026 - public comment period closes June 29, 2026 - proposal not yet final - 503A patient-specific pathway remains legally active - verify current status before enrolling Why This Update Article Exists: What Changed Between January and June 2026, and What Consumers Should Verify Before Enrolling A prior coverage piece looked at Shed's platform in January 2026 - and if you read it, some of what you learned has since changed

In this review, we provide background on GIP, GLP-1, and tirzepatide molecules and then further examine the evidence from mechanism-of-action studies of tirzepatide

Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats

The program includes monthly medication, dietary and exercise guidance, scheduled provider check-ins, and 24/7 access to on-call medical staff